184 related articles for article (PubMed ID: 10974581)
41. First two cases of severe multifocal infections caused by Klebsiella pneumoniae in Switzerland: characterization of an atypical non-K1/K2-serotype strain causing liver abscess and endocarditis.
Babouee Flury B; Donà V; Buetti N; Furrer H; Endimiani A
J Glob Antimicrob Resist; 2017 Sep; 10():165-170. PubMed ID: 28729207
[TBL] [Abstract][Full Text] [Related]
42. Changing bacteriology of adult community-acquired lung abscess in Taiwan: Klebsiella pneumoniae versus anaerobes.
Wang JL; Chen KY; Fang CT; Hsueh PR; Yang PC; Chang SC
Clin Infect Dis; 2005 Apr; 40(7):915-22. PubMed ID: 15824979
[TBL] [Abstract][Full Text] [Related]
43. Clinical and Genomic Analysis of Liver Abscess-Causing
Ye M; Tu J; Jiang J; Bi Y; You W; Zhang Y; Ren J; Zhu T; Cao Z; Yu Z; Shao C; Shen Z; Ding B; Yuan J; Zhao X; Guo Q; Xu X; Huang J; Wang M
Front Cell Infect Microbiol; 2016; 6():165. PubMed ID: 27965935
[TBL] [Abstract][Full Text] [Related]
44. Antimicrobial Resistance of Hypervirulent
Lee CR; Lee JH; Park KS; Jeon JH; Kim YB; Cha CJ; Jeong BC; Lee SH
Front Cell Infect Microbiol; 2017; 7():483. PubMed ID: 29209595
[No Abstract] [Full Text] [Related]
45. Risk factors for spontaneous rupture of liver abscess caused by Klebsiella pneumoniae.
Lee CH; Leu HS; Wu TS; Su LH; Liu JW
Diagn Microbiol Infect Dis; 2005 Jun; 52(2):79-84. PubMed ID: 15964493
[TBL] [Abstract][Full Text] [Related]
46. In vitro activities of 16 antimicrobial agents against clinical isolates of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in two regional hospitals in Taiwan.
Liao CH; Sheng WH; Wang JT; Sun HY; Wang HK; Hsueh PR; Chen YC; Chang SC
J Microbiol Immunol Infect; 2006 Feb; 39(1):59-66. PubMed ID: 16440125
[TBL] [Abstract][Full Text] [Related]
47. Epidemiology and molecular characterisation of colistin-resistant Klebsiella pneumoniae isolates from immunocompromised patients in Tunisia.
Tanfous FB; Raddaoui A; Chebbi Y; Achour W
Int J Antimicrob Agents; 2018 Dec; 52(6):861-865. PubMed ID: 30176353
[TBL] [Abstract][Full Text] [Related]
48. In vitro pharmacodynamics of colistin against multidrug-resistant Klebsiella pneumoniae.
Poudyal A; Howden BP; Bell JM; Gao W; Owen RJ; Turnidge JD; Nation RL; Li J
J Antimicrob Chemother; 2008 Dec; 62(6):1311-8. PubMed ID: 18922815
[TBL] [Abstract][Full Text] [Related]
49. Emerging invasive liver abscess caused by K1 serotype Klebsiella pneumoniae in Korea.
Chung DR; Lee SS; Lee HR; Kim HB; Choi HJ; Eom JS; Kim JS; Choi YH; Lee JS; Chung MH; Kim YS; Lee H; Lee MS; Park CK;
J Infect; 2007 Jun; 54(6):578-83. PubMed ID: 17175028
[TBL] [Abstract][Full Text] [Related]
50. Molecular characterization of the bla(KPC-2) gene in clinical isolates of carbapenem-resistant Klebsiella pneumoniae from the pediatric wards of a Chinese hospital.
Liu Y; Li XY; Wan LG; Jiang WY; Li FQ; Yang JH
Can J Microbiol; 2012 Oct; 58(10):1167-73. PubMed ID: 22978676
[TBL] [Abstract][Full Text] [Related]
51. Clinical and microbiological characteristics of community-acquired thoracic empyema or complicated parapneumonic effusion caused by Klebsiella pneumoniae in Taiwan.
Lin YT; Chen TL; Siu LK; Hsu SF; Fung CP
Eur J Clin Microbiol Infect Dis; 2010 Aug; 29(8):1003-10. PubMed ID: 20505967
[TBL] [Abstract][Full Text] [Related]
52. Tracking a hospital outbreak of KPC-producing ST11 Klebsiella pneumoniae with whole genome sequencing.
Jiang Y; Wei Z; Wang Y; Hua X; Feng Y; Yu Y
Clin Microbiol Infect; 2015 Nov; 21(11):1001-7. PubMed ID: 26166545
[TBL] [Abstract][Full Text] [Related]
53. Activity of ertapenem, ciprofloxacin, ceftriaxone, piperacillin-tazobactam, and ampicillin-sulbactam against 12 common clinical isolates of community-acquired bacteremia.
Hwang KP; Tang YF; Shen YH
J Microbiol Immunol Infect; 2009 Oct; 42(5):433-8. PubMed ID: 20182674
[TBL] [Abstract][Full Text] [Related]
54. Dissemination of multidrug-resistant blaCTX-M-15/IncFIIk plasmids in Klebsiella pneumoniae isolates from hospital- and community-acquired human infections in Tunisia.
Mansour W; Grami R; Ben Haj Khalifa A; Dahmen S; Châtre P; Haenni M; Aouni M; Madec JY
Diagn Microbiol Infect Dis; 2015 Nov; 83(3):298-304. PubMed ID: 26341707
[TBL] [Abstract][Full Text] [Related]
55. Epidemiology and clinical features of community-onset bacteremia caused by extended-spectrum β-lactamase-producing Klebsiella pneumoniae.
Lee JA; Kang CI; Joo EJ; Ha YE; Kang SJ; Park SY; Chung DR; Peck KR; Ko KS; Lee NY; Song JH
Microb Drug Resist; 2011 Jun; 17(2):267-73. PubMed ID: 21388296
[TBL] [Abstract][Full Text] [Related]
56. Emergence of KPC new variants (KPC-16 and KPC-17) and ongoing outbreak in southern Taiwan.
Yu WL; Lee MF; Tang HJ; Chang MC; Walther-Rasmussen J; Chuang YC
Clin Microbiol Infect; 2015 Apr; 21(4):347.e5-8. PubMed ID: 25634143
[TBL] [Abstract][Full Text] [Related]
57. The High mortality and antimicrobial resistance of Klebsiella pneumoniae bacteremia in northern Taiwan.
Chen CL; Hou PC; Wang YT; Lee HY; Zhou YL; Wu TS; Janapatla RP; Yang CC
J Infect Dev Ctries; 2020 Apr; 14(4):373-379. PubMed ID: 32379714
[TBL] [Abstract][Full Text] [Related]
58. A seven-year survey of Klebsiella pneumoniae producing TEM-24 extended-spectrum beta-lactamase in Nice University Hospital (1994-2000).
Giraud-Morin C; Fosse T
J Hosp Infect; 2003 May; 54(1):25-31. PubMed ID: 12767843
[TBL] [Abstract][Full Text] [Related]
59. Molecular epidemiology and antimicrobial susceptibility of extended- and broad-spectrum beta-lactamase-producing Klebsiella pneumoniae isolated in Portugal.
Mendonça N; Ferreira E; Louro D; ; Caniça M
Int J Antimicrob Agents; 2009 Jul; 34(1):29-37. PubMed ID: 19272757
[TBL] [Abstract][Full Text] [Related]
60. Clinical implications of hypermucoviscosity phenotype in Klebsiella pneumoniae isolates: association with invasive syndrome in patients with community-acquired bacteraemia.
Lee HC; Chuang YC; Yu WL; Lee NY; Chang CM; Ko NY; Wang LR; Ko WC
J Intern Med; 2006 Jun; 259(6):606-14. PubMed ID: 16704562
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
